EUVIMEDEUVIMED entdecken
Multizentrische Studie

Associations between molecular subtypes and high-risk pathological factors in endometrial cancer

Xueqing Sun, Jing Xue, Zhen Sun, Wei Tian, Xiao Song, Ran Chu, Ming Liu

Clinical and Translational Oncology · 2025

DOI: 10.1007/s12094-025-04089-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Xueqing Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, Shando…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Tumor Suppressor Protein p53, Biomarkers, Tumor. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Chinese Anti-Cancer Association, Shandong Lanpeng Technology Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Endometrial carcinoma (EC) molecular subtypes are critical for risk assessment and treatment guidance, with strong prognostic implications. OBJECTIVES: To investigate associations between EC molecular subtypes and high-risk pathological factors to optimize individualized therapy. DESIGN: Multicenter retrospective cohort study. METHODS: Retrospective analysis of 292 EC cases classified via the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) into four subtypes: POLE ultramutant (POLE-mut), mismatch repair deficient (MMRd), p53 abnormal (p53 abn), and p53 wild-type (p53 wt). Associations with clinicopathological parameters were assessed using chi-square tests and logistic regression. RESULTS: Among the 292 patients, the distribution of molecular subtypes was as follows: POLE-mut (6.8%), MMRd (21.2%), p53 abn (14.4%), and p53 wt (57.5%). Molecular subtypes correlated significantly with International Federation of Gynecology and Obstetrics (FIGO) stage (p < 0.001), poor/undifferentiated histology (p < 0.001), and lymphovascular space invasion (LVSI) (p = 0.001). The POLE-mut and p53 wt were predominantly enriched in stage I disease (90.0% and 80.4%, respectively). In contrast, the majority of p53 abn were classified as stage II (81.0%). The MMRd subtype was distributed across all stages. Advanced stages (III-IV) were most frequently observed in the p53 abn and MMRd subtypes. p53 abn showed the highest rate of poor/undifferentiated histology (61.9%). MMRd comprised the largest proportion of LVSI-positive cases (39.1%). Multivariate analysis identified MMRd as an independent predictor of LVSI (p = 0.001), while both MMRd (p = 0.009) and p53 abn (p < 0.001) independently predicted poor/undifferentiated histology. CONCLUSIONS: EC molecular subtypes stratify clinicopathological risk and predict tumor behavior, highlighting their potential utility in informing individualized management. These findings suggest possible roles ranging from treatment de-escalation (POLE‑mut) to treatment intensification (p53‑abn), although further prospective studies are needed before routine clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsTumor Suppressor Protein p53Biomarkers, TumorHumansFemaleRetrospective StudiesMiddle AgedAgedRisk FactorsDNA Polymerase IIDNA Mismatch RepairPoly-ADP-Ribose Binding ProteinsPrognosisAdultAged, 80 and overMutation

Stichwörter der Autor:innen

Endometrial cancerHigh-risk factorsMolecular subtypesPathological factorsProMisE

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanDNA Polymerase IIPoly-ADP-Ribose Binding ProteinsPOLE protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, Shandong Province, People's Republic of China.
  • Department of Obstetrics and Gynecology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, People's Republic of China.
  • Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, People's Republic of China.
  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, Shandong Province, People's Republic of China. l_ming1109@163.com.

Förderung

  • Chinese Anti-Cancer Association
  • Shandong Lanpeng Technology Co., Ltd.

Zitieren

APA

Sun, X., Xue, J., Sun, Z., Tian, W., Song, X., Chu, R., & Liu, M. (2025). Associations between molecular subtypes and high-risk pathological factors in endometrial cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04089-4

Vancouver

Sun X, Xue J, Sun Z, Tian W, Song X, Chu R, et al. Associations between molecular subtypes and high-risk pathological factors in endometrial cancer. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04089-4

BibTeX
@article{Sun2025,
  author = {Sun, Xueqing and Xue, Jing and Sun, Zhen and Tian, Wei and Song, Xiao and Chu, Ran and Liu, Ming},
  title = {Associations between molecular subtypes and high-risk pathological factors in endometrial cancer},
  journal = {Clinical and Translational Oncology},
  year = {2025},
  doi = {10.1007/s12094-025-04089-4}
}
Kostenlos starten →